Company news from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Astrazeneca's Enhertu secures EU approval
Tue 27 October 2026 11:21
(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that Enhertu has been approved in the European Union as an adjuvant treatment for adults with HER2‑positive early breast cancer who still have signs of invasive disease after initial chemotherapy
Informa maintains earnings outlook despite Middle East disruption
Tue 27 October 2026 08:22
(Sharecast News) - Informa maintained its full-year earnings growth guidance on Tuesday despite further disruption to events in the Middle East, although it warned that revenue growth could slow significantly if trading in Saudi Arabia remained suspended.
Reckitt cuts full-year sales outlook after weaker third quarter
Tue 27 October 2026 07:09
(Sharecast News) - Reckitt Benckiser cut its full-year sales growth guidance on Tuesday after third-quarter trading fell short of expectations, hit by manufacturing constraints in North America and weaker demand for vitamins and supplements in China.
Molten Ventures trades higher following strong H1 NAV growth
Mon 26 October 2026 13:55
(Sharecast News) - Investment firm Molten Ventures shares were higher on Monday after the firm posted a strong first‑half trading update, with solid net asset value growth, sizeable realisations and fresh progress on scaling third‑party capital.
GSK reports encouraging data in ovarian and rectal cancer studies
Mon 26 October 2026 09:29
(Sharecast News) - Drugmaker GSK reported two sets of encouraging cancer‑drug results on Monday, with fresh data for its experimental ovarian‑cancer therapy Mo‑Rez and new interim findings for Jemperli in rectal cancer, both due to be presented at t